• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

    19.66 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 22
    Open 19.66
    Bid (Size) 18.50 (500)
    Ask (Size) 20.76 (100)
    Prev. Close 19.66
    Today's Range 19.66 - 19.66
    52wk Range 7.900 - 21.03
    Shares Outstanding 49,471,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
    Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide. 
    Via The Motley Fool
    News headline image
    Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
    Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +8.3%
    +8.3%
    1 Month
    -2.9%
    -2.9%
    3 Month
    +6.3%
    +6.3%
    6 Month
    +42.5%
    +42.5%
    1 Year
    +121.9%
    +121.9%

    More News

    Read More
    News headline image
    Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Irenic Dumps Most Papa John's Shares ↗
    Via The Motley Fool
    Topics ETFs Regulatory Compliance
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Friday. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
    Via The Motley Fool
    News headline image
    Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
    Via The Motley Fool
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Here's Why Shares in Theravance Biopharma Exploded Today ↗
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction ↗
    Via Chartmill
    Topics Earnings
    News headline image
    PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
    From Theravance Biopharma
    Via Business Wire
    News headline image
    This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗
    Via Benzinga
    News headline image
    Theravance Sales Jump 83 Percent ↗
    Via The Motley Fool
    News headline image
    Theravance Biopharma Inc (NASDAQ:TBPH) Misses Q2 2025 Revenue and EPS Estimates Amid Mixed Market Reaction ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Earnings Scheduled For August 12, 2025 ↗
    Via Benzinga

    Frequently Asked Questions

    Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
    Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
    What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
    Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
    The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
    What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
    The current price of Theravance Biopharma, Inc. - Ordinary Shares is 19.66
    When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
    The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 02/20/26 04:00 PM ET
    What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
    The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 972.60M
    How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
    Theravance Biopharma, Inc. - Ordinary Shares has 973M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.